Détail de l'auteur
Auteur Mirabella M |
Documents disponibles écrits par cet auteur (32)



![]()
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients
Garibaldi M, Fionda L, Vanoli F, et al.
Autoimmunity reviews, 2020
Revue : Autoimmunity reviews Titre : Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients Type de document : Article Auteurs : Garibaldi M, Auteur ; Fionda L ; Vanoli F ; Leonardi L ; Loreti S ; Bucci E ; Di Pasquale A ; Morino S ; Vizzaccaro E ; Merlonghi G ; Ceccanti M ; Lucchini M ; Mirabella M ; Andreetta F ; Pennisi EM ; Petrucci A ; Salvetti M ; Antonini G Editeur : Netherlands Année de publication : 02/2020 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 32062029 / DOI : 10.1016/j.autrev.2020.102498
N° Profil MNM : 2020022 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/32062029 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
Hanna MG, Badrising UA, Benveniste O, et al.
The Lancet. Neurology, 2019, 18, 9, p 834
Revue : The Lancet. Neurology, 18, 9 Titre : Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial Type de document : Article Auteurs : Hanna MG, Auteur ; Badrising UA ; Benveniste O ; Lloyd TE ; Needham M ; Chinoy H ; Aoki M ; Machado PM ; Liang C ; Reardon KA ; de Visser M ; Ascherman DP ; Barohn RJ ; Dimachkie MM ; Miller JAL ; Kissel JT ; Oskarsson B ; Joyce NC ; van den Bergh P ; Baets J ; De Bleecker JL ; Karam C ; David WS ; Mirabella M ; Nations SP ; Jung HH ; Pegoraro E ; Maggi L ; Rodolico C ; Filosto M ; Shaibani AI ; Sivakumar K ; Goyal NA ; Mori-Yoshimura M ; Yamashita S ; Suzuki N ; Katsuno M ; Murata K ; Nodera H ; Nishino I ; Romano CD ; Williams VSL ; Vissing J ; Auberson LZ ; Wu M ; de Vera A ; Papanicolaou DA ; Amato AA Editeur : England Année de publication : 09/2019 Pages : p 834 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 31397289 / DOI : 10.1016/S1474-4422(19)30200-5
N° Profil MNM : 2019082 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/31397289 Voir aussiAvis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy.
Lochmuller H, Behin A, Caraco Y, et al.
Neurology, 2019, 92, n18, e2109-e2117
Revue : Neurology, 92, n18 Titre : A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy. Type de document : Article Auteurs : Lochmuller H, Auteur ; Behin A ; Caraco Y ; Lau H ; Mirabella M ; Tournev I ; Tarnopolsky M ; Pogoryelova O ; Woods C ; Lai A ; Shah J ; Koutsoukos T ; Skrinar A ; Mansbach H ; Kakkis E ; Mozaffar T Editeur : United States Année de publication : 04/2019 Pages : e2109-e2117 Langues : Anglais (eng) Pubmed / DOI : Pubmed : 31036580 / DOI : 10.1212/WNL.0000000000006932
N° Profil MNM : 2019051 En ligne : http://www.ncbi.nlm.nih.gov/pubmed/31036580 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Muscle Resonance Imaging pattern recognition in sporadic Inclusion Body Myositis.
Tasca G, Monforte M, De Fino C, et al.
Muscle & Nerve, 2015, 52, 6, p. 956-62
Revue : Muscle & Nerve, 52, 6 Titre : Muscle Resonance Imaging pattern recognition in sporadic Inclusion Body Myositis. Type de document : Article Auteurs : Tasca G ; Monforte M ; De Fino C ; Kley RA ; Ricci E ; Mirabella M Année de publication : 12/2015 Pages : p. 956-62 Langues : Anglais (eng) Résumé : INTRODUCTION: In sporadic inclusion body myositis (IBM), additional tools are needed to confirm the diagnosis, particularly in clinically atypical or pathologically unproven patients. The aims of this study were to refine the pattern of muscle MRI in IBM and to assess its accuracy in differentiating IBM frorm other myopathies that overlap with it clinically or pathologically.
METHODS: Blind assessment of the scans of 17 definite IBM, 2 possible IBM, and 118 patients with other myopathies.
RESULTS: The diagnostic accuracy to detect definite IBM was 95% for the typical pattern (with 100% specificity) and 97% for both typical and consistent patterns (with 97% specificity).
DISCUSSION: Muscle MRI is an accurate tool for diagnostic workup of suspected IBM patients and may be particularly helpful in patients with early disease or who lack the classical IBM pathology. This article is protected by copyright. All rights reserved.Pubmed / DOI : DOI : 10.1002/mus.24661 / Pubmed : 25808807
En ligne : http://www.ncbi.nlm.nih.gov/pubmed/25808807 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Hereditary inclusion-body myopathies
Broccolini A, Mirabella M
Biochimica et biophysica acta, 2015, 1852, 4, p 644
Revue : Biochimica et biophysica acta, 1852, 4 Titre : Hereditary inclusion-body myopathies Type de document : Article Auteurs : Broccolini A ; Mirabella M Année de publication : 2015 Pages : p 644 Langues : Anglais (eng) Mots-clés : article de synthèse ; chaîne lourde de la myosine ; étude transversale ; examen clinique ; gène GNE ; immunofluorescence ; myopathie à inclusions avec maladie de Paget et démence frontotemporale ; myopathie à inclusions de type 2 ; myopathie à inclusions de type 3 ; physiopathologie ; protéine contenant la valosine ; UDP-N-acétylglucosamine-2-épimérase / N-acétylmannosamine kinase (maladie liée à) Pubmed / DOI : DOI : 10.1016/j.bbadis.2014.08.007 / Pubmed : 25149037
En ligne : http://www.ncbi.nlm.nih.gov/pubmed/25149037 Avis des lecteurs Aucun avis, ajoutez le vôtre !
(mauvais) 15 (excellent)
![]()
Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients
Gidaro T, Negroni E, Périé S, et al.
Journal of neuropathology and experimental neurology, 2013, 72, 3, p. 234-243
Permalink![]()
Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients
Gidaro T, Negroni E, Périé S, et al.
Journal of neuropathology and experimental neurology, 2013, 72, 3, p 234
Permalink![]()
Muscle MRI in female carriers of dystrophinopathy
Tasca G, Monforte M, Iannaccone E, et al.
European journal of neurology, 2012, 19, 9, p. 1256-1260
Permalink![]()
Muscle imaging findings in GNE myopathy
Tasca G, Ricci E, Monforte M, et al.
Journal of neurology, 2012, 259, 7, p. 1358-1365
Permalink![]()
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle
Broccolini A, Gidaro T, Morosetti R, et al.
Acta myologica, 2011, 30, 2, p. 91-95
Permalink![]()
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior
Morosetti R, Gidaro T, Broccolini A, et al.
Cell transplantation, 2011, 20, 8, p. 1299-1313
Permalink![]()
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis
Sancricca C, Mora M, Ricci E, et al.
Neurological sciences, 2011, 32, 5, p. 841-847
Permalink![]()
Increased aging in primary muscle cultures of sporadic inclusion-body myositis
Morosetti R, Broccolini A, Sancricca C, et al.
Neurobiology of aging, 2010, 31, 7, p. 1205-1214
Permalink![]()
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy
Broccolini A, Gidaro T, Tasca G, et al.
Neurology, 2010, 75, 3, p. 265-272
Permalink![]()
Hereditary inclusion-body myopathy : clues on pathogenesis and possible therapy
Broccolini A, Gidaro T, Morosetti R, et al.
Muscle & Nerve, 2009, 40, 3, p. 340-349
Permalink![]()
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene
Gidaro T, Modoni A, Sabatelli M, et al.
Muscle & Nerve, 2008, 37, 1, p. 111-114
Permalink![]()
Gene expression analysis in MRI positive FSHD muscles (Poster)
Collectif, Pescatori M, Tasca G, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 728
Permalink![]()
Partial caveolin 3 deficiency in acquired rippling muscle disease (Poster)
Collectif, Mirabella M, Charlton R, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 767
Permalink![]()
Transient overexpression of the Rho family exchange factor GEFT stimulates myogenic differentiation of inclusion-body myositis (IBM) mesoangioblasts (Poster)
Collectif, Morosetti R, Gliubizzi C, et al.
Neuromuscular disorders : NMD, 2008, 18, 9-10, p. 770
Permalink![]()
Gene expression profiling in the early phases of DMD : a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression
Pescatori M, Broccolini A, Minetti C, et al.
FASEB journal (The), 2007, 21, 4, p. 1210-1226
Permalink![]()
Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies
Morosetti R, Mirabella M, Gliubizzi C, et al.
Stem cells, 2007, 25, 12, p. 3173-3182
Permalink![]()
NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations
Ricci E, Broccolini A, Gidaro T, et al.
Neurology, 2006, 66, 5, p. 755-758
Permalink![]()
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study
Mercuri E, Messina S, Battini R, et al.
Neuromuscular disorders : NMD, 2006, 16, 2, p. 93-98
Permalink![]()
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle
Morosetti R, Mirabella M, Gliubizzi C, et al.
Proceedings of the national Academy of sciences of the United States of America, 2006, 103, 45, p. 16995-17000
Permalink![]()
Pilot trial of phenylbutyrate in spinal muscular atrophy
Mercuri E, Bertini E, Messina S, et al.
Neuromuscular disorders : NMD, 2004, 14, 2, p. 130-135
Permalink